UPD 24.03.2025 - Vaccination has emerged as a crucial preventative tool in the management of asthma, a chronic respiratory condition that affects millions worldwide. Individuals with asthma are particularly vulnerable to respiratory infections, which can trigger severe exacerbations, hospitalizations, and even life-threatening complications. Recent studies have shown that respiratory viruses are responsible for up to 80% of asthma flare-ups, underscoring the importance of immunization in preventing these episodes. Vaccines such as the seasonal influenza shot, pneumococcal vaccine, and the COVID-19 vaccine have demonstrated significant benefits in reducing infection rates and lessening the severity of illness among people with asthma. Public health authorities, including the CDC and WHO, recommend that individuals with asthma remain up to date with their vaccinations to minimize the risk of complications and maintain respiratory health. Moreover, emerging research suggests that timely immunization not only prevents acute episodes but may also contribute to long-term control of asthma symptoms by reducing inflammatory responses triggered by infections. As vaccine technology continues to evolve, its role in comprehensive asthma care becomes even more indispensable, offering a proactive strategy to protect one of the most at-risk populations from avoidable harm.
04.01.2025 - Yes, in the United States, certain inhalers are available over-the-counter (OTC) without the need for a doctor's prescription. Primatene Mist, which contains epinephrine, is one such inhaler approved by the FDA for temporary relief of mild, intermittent asthma symptoms. However, it's important to note that while OTC inhalers can provide short-term relief, they are not substitutes for prescription inhalers, which are often more effective for managing moderate to severe asthma. Consulting with a healthcare provider is recommended to ensure appropriate treatment and to discuss whether an OTC inhaler is suitable for your specific condition.